Assessment of the Dexmedetomidin effect on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170411033365N2

Enrollment

Registered

2021-11-10

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing laparoscopic cholecystectomy.

Interventions

Intervention group:Dexmedetomidine group.

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Adult Patients with Physical Status I-II of the American Society of Anesthesiologists (ASA) undergoing laparoscopic cholecystectomy for acute and chronic cholecystitis

Exclusion criteria

Exclusion criteria: Sensitivity to drugs in the study, receiving antiemetic drugs in the last 48 hours before surgery and body mass index above 35 kg / m2, surgery more than 2 hours, other concomitant surgery, complications during or after surgery and dissatisfaction with the company in this study

Design outcomes

Primary

Measure	Time frame
Nausea / vomiting. Timepoint: recovery. Method of measurement: A score of zero was equivalent to no nausea or vomiting and a score of 5 was equivalent to the highest severity of nausea or vomiting.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ebrahim Hassani

Oroumia University of Medical Sciences

mahouri.a@umsu.ac.ir+98 44 3198 8327

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026